scispace - formally typeset
C

Carlos A Guerra

Researcher at University of Oxford

Publications -  34
Citations -  11144

Carlos A Guerra is an academic researcher from University of Oxford. The author has contributed to research in topics: Malaria & Population. The author has an hindex of 28, co-authored 31 publications receiving 10649 citations. Previous affiliations of Carlos A Guerra include Kenyatta National Hospital & Center for Disease Dynamics, Economics & Policy.

Papers
More filters
Journal ArticleDOI

The global distribution of clinical episodes of Plasmodium falciparum malaria

TL;DR: It is estimated that there were 515 (range 300–660) million episodes of clinical P. falciparum malaria in 2002, up to 50% higher than those reported by the World Health Organization and 200% higher for areas outside Africa, reflecting the WHO's reliance upon passive national reporting for these countries.
Journal ArticleDOI

A world malaria map: Plasmodium falciparum endemicity in 2007

TL;DR: This 2007 global P. falciparum malaria endemicity map is the first of a series with which it will be possible to monitor and evaluate the progress of this intervention process, and shows significant opportunities for malaria control in Africa and for malaria elimination elsewhere.
Journal ArticleDOI

The global distribution and population at risk of malaria: past, present, and future

TL;DR: This paper used geographic information systems in combination with historical maps to quantify the anthropogenic impact on the distribution of malaria in the 20th century, finding that despite human activities reducing by half the land area supporting malaria, demographic changes resulted in a 2 billion increase in the total population exposed to malaria risk.
Journal ArticleDOI

Vivax Malaria: Neglected and Not Benign

TL;DR: Progress in reducing the burden of disease will require improved access to reliable diagnosis and effective treatment of both blood-stage and latent parasites, and more detailed characterization of the epidemiology, morbidity, and economic impact of vivax malaria.